Login / Signup

Response to Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.

Francesca D'AddioPaolo Fiorina
Published in: Diabetes (2022)
Keyphrases
  • sars cov
  • type diabetes
  • cardiovascular disease
  • respiratory syndrome coronavirus
  • glycemic control
  • binding protein
  • metabolic syndrome